Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated:  3/26/2012
Access Community Health Network
mi
from
Chicago, IL
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated: 3/26/2012
Access Community Health Network
mi
from
Chicago, IL
Click here to add this to my saved trials
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated:  3/26/2012
University of Illinois Hospital & Health Sciences System
mi
from
Chicago, IL
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening
Status: Enrolling
Updated: 3/26/2012
University of Illinois Hospital & Health Sciences System
mi
from
Chicago, IL
Click here to add this to my saved trials
Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
A Pilot Study of the Utility of the Novel Amino Acid Radiotracer Anti-[18 F]FACBC for the Noninvasive Imaging of Lung Nodules
Status: Archived
Updated:  3/27/2012
Emory University
mi
from
Atlanta, GA
Amino Acid Tracer (FACBC) Positron Emission Tomography for Lung Nodule
A Pilot Study of the Utility of the Novel Amino Acid Radiotracer Anti-[18 F]FACBC for the Noninvasive Imaging of Lung Nodules
Status: Archived
Updated: 3/27/2012
Emory University
mi
from
Atlanta, GA
Mindfulness Therapy for Individuals With Lung Cancer
Status: Enrolling
Updated:  3/27/2012
Michigan State University
mi
from
East Lansing, MI
Mindfulness Therapy for Individuals With Lung Cancer
Status: Enrolling
Updated: 3/27/2012
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Mindfulness Therapy for Individuals With Lung Cancer
Status: Enrolling
Updated:  3/27/2012
Allegiance Health
mi
from
Jackson, MI
Mindfulness Therapy for Individuals With Lung Cancer
Status: Enrolling
Updated: 3/27/2012
Allegiance Health
mi
from
Jackson, MI
Click here to add this to my saved trials
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
A Phase I/II Trial of the Combination of Cisplatin, Cetuximab, and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated:  3/28/2012
University of Tennessee Cancer Institute
mi
from
Knoxville, TN
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
A Phase I/II Trial of the Combination of Cisplatin, Cetuximab, and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 3/28/2012
University of Tennessee Cancer Institute
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Sutter East Bay Hospitals
mi
from
Berkley, CA
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Sutter East Bay Hospitals
mi
from
Berkley, CA
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Palm Springs Research Institute
mi
from
Hialeah, FL
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
MCG Cancer Center
mi
from
Augusta, GA
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
MCG Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Joliet Oncology-Hematology Associates, Ltd.
mi
from
Joliet, IL
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Joliet Oncology-Hematology Associates, Ltd.
mi
from
Joliet, IL
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Kansas University Medical Center
mi
from
Kansas City, KA
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
University of Kentucky Markey Cancer Center Clinical Research Organization
mi
from
Lexington, KY
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
University of Kentucky Markey Cancer Center Clinical Research Organization
mi
from
Lexington, KY
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Nevada Cancer Institute
mi
from
Las Vegas, NV
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Nevada Cancer Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Montefiore Medical Center
mi
from
Bronx, NY
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Mid Dakota Clinical P.C. - Cancer Treatment and Research Center
mi
from
Bismarck, ND
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Mid Dakota Clinical P.C. - Cancer Treatment and Research Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Gabrail Cancer Center
mi
from
Canton, OH
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Pharma Resource
mi
from
East Providence, RI
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Pharma Resource
mi
from
East Providence, RI
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated:  3/29/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
Status: Enrolling
Updated: 3/29/2012
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
Status: Enrolling
Updated:  4/5/2012
OU Health Sciences Center
mi
from
Oklahoma City, OK
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
Status: Enrolling
Updated: 4/5/2012
OU Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Status: Enrolling
Updated:  4/6/2012
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
Status: Enrolling
Updated: 4/6/2012
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Status: Enrolling
Updated:  4/9/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Status: Enrolling
Updated: 4/9/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
T-Regulatory Cell Kinetics Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
Status: Enrolling
Updated:  4/10/2012
Texas Children's Hospital
mi
from
Houston, TX
Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
T-Regulatory Cell Kinetics Post Transplant For Patients Undergoing Matched Sibling Stem Cell Transplantation
Status: Enrolling
Updated: 4/10/2012
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Animal Assisted Therapy in a Pediatric Setting
The Effectiveness of Animal Assisted Therapy for Children Hospitalized in a Pediatric Setting
Status: Enrolling
Updated:  4/11/2012
Children's Hopsitals and Clinics of Minnesota
mi
from
St. Paul, MN
Animal Assisted Therapy in a Pediatric Setting
The Effectiveness of Animal Assisted Therapy for Children Hospitalized in a Pediatric Setting
Status: Enrolling
Updated: 4/11/2012
Children's Hopsitals and Clinics of Minnesota
mi
from
St. Paul, MN
Click here to add this to my saved trials
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Status: Enrolling
Updated:  4/18/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
Status: Enrolling
Updated: 4/18/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NON-INVASIVE BIOMARKERS FOR EARLY DETECTION OF LUNG CANCERS: ELEMENT 1: NON-RANDOMIZED PHASE II EVALUATION AND VALIDATION IN NEWLY DIAGNOSED LUNG CANCER PATIENTS
Status: Enrolling
Updated:  4/18/2012
Baptist Cancer Institute, Baptist Medical Center
mi
from
Jacksonville, FL
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NON-INVASIVE BIOMARKERS FOR EARLY DETECTION OF LUNG CANCERS: ELEMENT 1: NON-RANDOMIZED PHASE II EVALUATION AND VALIDATION IN NEWLY DIAGNOSED LUNG CANCER PATIENTS
Status: Enrolling
Updated: 4/18/2012
Baptist Cancer Institute, Baptist Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Exercise and Relaxation Intervention for Young Adult Cancer Survivors
Status: Enrolling
Updated:  4/19/2012
Miriam Hospital
mi
from
Providence, RI
Exercise and Relaxation Intervention for Young Adult Cancer Survivors
Status: Enrolling
Updated: 4/19/2012
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
RAD 0901- Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Status: Enrolling
Updated:  4/20/2012
UAB
mi
from
Birmingham, AL
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
RAD 0901- Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Status: Enrolling
Updated: 4/20/2012
UAB
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Improved Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Status: Enrolling
Updated:  4/25/2012
Massachusetts General Hospital
mi
from
Boston, MA
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Improved Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Status: Enrolling
Updated: 4/25/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology Centers of Alabama
mi
from
Homewood, AL
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology Centers of Alabama
mi
from
Homewood, AL
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
South Orange County Urology Research
mi
from
Laguna Hills, CA
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
South Orange County Urology Research
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
San Bernadino Urological Association
mi
from
San Bernadino, CA
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
San Bernadino Urological Association
mi
from
San Bernadino, CA
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
South Florida Medical Research
mi
from
Miami, FL
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
South Florida Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Carolina Clinical Trials
mi
from
Concord, NC
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Carolina Clinical Trials
mi
from
Concord, NC
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology Clinic of North Texas
mi
from
Dallas, TX
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology Clinic of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated:  4/26/2012
Urology San Antonio Research
mi
from
San Antonio, TX
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Open-label, Multi-centre, Parallel Group Dose-Escalation Trial Assessing the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer
Status: Enrolling
Updated: 4/26/2012
Urology San Antonio Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients
Quality of Life Outcomes Following Mind-body Skills Training for Cancer Patients That Are Facilitated Either Face-to-face or Online: A Pilot Study
Status: Enrolling
Updated:  4/26/2012
Absenger Cancer Education Foundation
mi
from
Spring Lake, MI
A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients
Quality of Life Outcomes Following Mind-body Skills Training for Cancer Patients That Are Facilitated Either Face-to-face or Online: A Pilot Study
Status: Enrolling
Updated: 4/26/2012
Absenger Cancer Education Foundation
mi
from
Spring Lake, MI
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology-Scottsdale
mi
from
Scottsdale, AZ
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology-Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology - Santa Monica
mi
from
Santa Monica, CA
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology - Santa Monica
mi
from
Santa Monica, CA
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology
mi
from
Cape Coral, FL
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology
mi
from
Cape Coral, FL
Click here to add this to my saved trials
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated:  4/27/2012
21st Century Oncology - Plantation
mi
from
Plantation, FL
The AIM Study: Assessing the Impact of Margin Reduction
The AIM Study: Assessing the Impact of Margin Reduction
Status: Enrolling
Updated: 4/27/2012
21st Century Oncology - Plantation
mi
from
Plantation, FL
Click here to add this to my saved trials
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
A Phase I Study of the mTOR Inhibitor Temsirolimus Plus Capecitabine in Patients With Advanced Malignancies
Status: Enrolling
Updated:  4/30/2012
Georgetown University Medical Center
mi
from
Washington,
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
A Phase I Study of the mTOR Inhibitor Temsirolimus Plus Capecitabine in Patients With Advanced Malignancies
Status: Enrolling
Updated: 4/30/2012
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
A Phase II Study of Tacrolimus and Thymoglobulin, as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Related Donor Hematopoietic Cell Transplantation
Status: Enrolling
Updated:  4/30/2012
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
A Phase II Study of Tacrolimus and Thymoglobulin, as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Related Donor Hematopoietic Cell Transplantation
Status: Enrolling
Updated: 4/30/2012
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
A Phase I/ II, Multi-center, Open-label Study, to Evaluate the Efficacy of AUY922 in Combination With Lapatinib With Letrozole in Postmenopausal Patients With Locally Advanced or Metastatic ER+ , HER2 + Breast Cancer
Status: Enrolling
Updated:  5/1/2012
Texas Tech University Health Sciences Center
mi
from
Odessa, TX
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
A Phase I/ II, Multi-center, Open-label Study, to Evaluate the Efficacy of AUY922 in Combination With Lapatinib With Letrozole in Postmenopausal Patients With Locally Advanced or Metastatic ER+ , HER2 + Breast Cancer
Status: Enrolling
Updated: 5/1/2012
Texas Tech University Health Sciences Center
mi
from
Odessa, TX
Click here to add this to my saved trials
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  5/4/2012
Thomas Jefferson University [Kimmel Cancer Center]
mi
from
Philadelphia, PA
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 5/4/2012
Thomas Jefferson University [Kimmel Cancer Center]
mi
from
Philadelphia, PA
Click here to add this to my saved trials
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  5/4/2012
UPMC Liver Cancer Center
mi
from
Pittsburgh, PA
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 5/4/2012
UPMC Liver Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  5/4/2012
The Liver Institute at Methodist Dallas
mi
from
Dallas, TX
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 5/4/2012
The Liver Institute at Methodist Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  5/4/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A Pilot Study of Yttrium-90 Microspheres (SIR-Spheres®) Therapy for the Treatment of Unresectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 5/4/2012
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials